Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Point of Care Data Management Software has become emerging market since many decades. The management software significantly provides the precise health care records with patient’s history, laboratory diagnostic results, treatment plans. Besides, it provides easy accessibility to the physicians by immediate reporting of results and reducing transcription errors. The market is expected to witness growth at a significant rate during the forecast period.
The market is driven by increasing initiatives accelerating adoption of electronic health records (EHR). The growing use of the electronic health records for recording patient history, diagnosis, treatment plans, laboratory and test results is driving the growth of the market. Besides, innovation in flexible connectivity and software interface solutions has led the robust demand of point of care data management software market. The software majorly helps in the making possible diagnosis based test results and precise identification for the treatment.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the point of care data management software market. In addition, complete analysis of changes on the point of care data management software market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market.
The point of care data management software market is segmented based on component, mode of delivery, application, end user and geography.
The point of care data management software is available in market according to component like services, software. Services is expected to lead in the market due to growing usage of component in the market.
The point of care data management software are through different mode of delivery including cloud based, on-premise. On-premise is expected to dominate in the market owing to increasing use in the hospital and clinics for different application and end use.
The point of care data management software market find its application in cancer markers, cardiometabolic monitoring, coagulation monitoring, glucose monitoring, hematology, infectious disease devices, and urinalysis. Cardiometabolic monitoring is expected to have major use of point of care data management software market. The increasing cases of cardiology globally has led the demand for market. In addition, the precise management for treatment, monitoring, appointment registration has fuel the growth of the point of care data management software market
The point of care data management software market has key end user in hospitals/critical care units, diagnostic centers. Hospitals/critical care units is projected to lead in the global point of care data management software market. The growth is attributed to increasing patients in hospitals thereby increasing need for the precise hospital administration process like billing, scheduling patient’s appointment. Besides, easy and rapid diagnosis via Point of Care Data Management Software is propelling the demand for the market.
Geographically point of care data management software market is studied for the following region North America, Europe, Asia Pacific and RoW. North America is anticipated to lead in the Point of Care Data Management Software attributing to developed healthcare facilities. Besides increasing burden of different disease has led the demand for market. In addition changing lifestyle and increasing environmental pollution has given a rise in the demand for point of care data management software market. Whereas Europe is expected to growth at a significant rate during the forecast period. The growth is due to increasing products innovation and launches in the region. However, Asia Pacific is projected to witness growth at the highest pace during the forecast period. Besides increasing product innovation and launches in the region is driving the growth of the market
The key players in point of care data management software market are Abbott Point of Care Inc. (Alere), Danaher Company (HemoCue and Radiometer Medical ApS), ESAOTE SPA, Hedera Biomedics SRL, HemoCue, Orchard Software Corporation, POC Medical System, Radiometer Medical ApS, Randox Laboratories Ltd, Roche Diagnostics Corporation, Seaward Electronic Ltd, Siemens Healthineers AG (Conworx), TELCOR Inc. and Thermo Fisher Scientific Inc. among others.
The report analyses the global point of care data management software market based on component, mode of delivery, application, end user and geography. The point of care data management software is available in market according to component like services, software. The point of care data management software are through different mode of delivery including cloud based, on-premise. The point of care data management software market find its application in cancer markers, cardiometabolic monitoring, coagulation monitoring, glucose monitoring, hematology, infectious disease devices, and urinalysis .The market has key end user in hospitals/critical care units, diagnostic centers. Geographically point of care data management software market is studied for the following region North America, Europe, Asia Pacific and RoW.
The key players in point of care data management software market are Abbott Point of Care Inc. (Alere), Danaher Company (HemoCue and Radiometer Medical ApS), ESAOTE SPA, Hedera Biomedics SRL, HemoCue, Orchard Software Corporation, POC Medical System, Radiometer Medical ApS, Randox Laboratories Ltd, Roche Diagnostics Corporation, Seaward Electronic Ltd, Siemens Healthineers AG (Conworx), TELCOR Inc. and Thermo Fisher Scientific Inc. among others.
Why to buy this report:
